These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12486276)

  • 1. Connecting impairment, disability, and handicap in immune mediated polyneuropathies.
    Merkies IS; Schmitz PI; van der Meché FG; Samijn JP; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):99-104. PubMed ID: 12486276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.
    Merkies IS; Schmitz PI; van der Meché FG; Samijn JP; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2002 May; 72(5):596-601. PubMed ID: 11971045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between impairment and disability scales in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI; Van Der Meché FG; Van Doorn PA
    Muscle Nerve; 2003 Jul; 28(1):93-100. PubMed ID: 12811779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
    Merkies IS; Schmitz PI; van der Meché FG; van Doorn PA
    Neurology; 2000 Feb; 54(4):943-9. PubMed ID: 10690990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.
    Galassi G; Tondelli M; Ariatti A; Benuzzi F; Nichelli P; Valzania F
    Int J Neurosci; 2017 May; 127(5):439-447. PubMed ID: 27188752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI; Van Der Meché FG; Samijn JP; Van Doorn PA
    Muscle Nerve; 2002 Mar; 25(3):370-7. PubMed ID: 11870713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):970-2. PubMed ID: 16549419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
    Merkies IS; Schmitz PI; Samijn JP; van der Meché FG; van Doorn PA
    Neurology; 1999 Nov; 53(8):1648-54. PubMed ID: 10563607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of five stroke scales with measures of disability, handicap, and quality of life.
    De Haan R; Horn J; Limburg M; Van Der Meulen J; Bossuyt P
    Stroke; 1993 Aug; 24(8):1178-81. PubMed ID: 8342193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI; Samijn JP; Meché FG; Toyka KV; van Doorn PA
    Muscle Nerve; 2000 Sep; 23(9):1393-401. PubMed ID: 10951442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of disability and handicap among Toxic Oil Syndrome (TOS) cohort patients: a cross-sectional study, 17 years after the original food intoxication.
    Martín-Arribas MC; Izquierdo Martínez M; de Andrés Copa P; Ferrari Arroyo MJ; Posada de la Paz M
    Disabil Rehabil; 2003 Oct; 25(20):1158-67. PubMed ID: 14534059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
    Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies.
    Molenaar DS; de Haan R; Vermeulen M
    J Neurol Neurosurg Psychiatry; 1995 Aug; 59(2):165-9. PubMed ID: 7629531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Classification of Impairments, Disabilities and Handicaps (ICIDH)--results and problems.
    Schuntermann MF
    Int J Rehabil Res; 1996 Mar; 19(1):1-11. PubMed ID: 8730539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ICIDH: evolution, status, and prospects.
    Thuriaux MC
    Disabil Rehabil; 1995; 17(3-4):112-8. PubMed ID: 7787193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disability, resources, role demands and mobility handicap.
    McDonough PA; Badley EM; Tennant A
    Disabil Rehabil; 1995; 17(3-4):159-68. PubMed ID: 7787199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ICIDH: format, application in different settings, and distinction between disability and handicap. A critique of papers on the application of the International Classification of Impairments, Disabilities, and Handicaps.
    Badley EM
    Int Disabil Stud; 1987; 9(3):122-5. PubMed ID: 2962978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
    Chaudhry V; Cornblath DR
    J Peripher Nerv Syst; 2010 Sep; 15(3):196-201. PubMed ID: 21040141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sense of coherence - a mediator between disability and handicap?
    Schnyder U; Büchi S; Mörgeli H; Sensky T; Klaghofer R
    Psychother Psychosom; 1999; 68(2):102-10. PubMed ID: 10026462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.